Investigational MRI Clinical Software and Hardware

Conditions

• Image, Body

Eligibility Criteria

Sex

ALL

Age

18 Years - 90 Years

Healthy Volunteers

Accepted

Interventions

• MRI — RADIATION
  1.5T or 3T MRI scanner (Siemens Medical Systems)
• Gadavist 2Ml Solution for Injection — DRUG
  Arm 1 and Arm 3 subjects will undergo this intervention (Gadavist 2Ml solution)

Study Details

Patients and healthy volunteers will be scanned in order to test new sequences.

Key Dates

Start date

Dec 19, 2019

Status verified

Apr 2026

Primary completion

Jan 31, 2028

Completion

Jan 31, 2028

Study Design

Enrollment

2,000 participants (estimated)

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Arms

• Other: Patient w/ Contrast
  Patients will add 15 minutes to their SOC MRI for research purposes
• Other: Patient no contrast
  Patients will add 15 minutes to their SOC MRI for research purposes
• Other: Volunteer w/ contrast
  Volunteers undergo 1 research MRI for research purposes
• Other: Volunteer no contrast
  Volunteers undergo 1 research MRI for research purposes

Primary Outcome Measure

Conduct clinical protocol development and validation [ Time Frame: 5 years ]

Central Contacts

• Emily Powell
  312.695.2956
  [email protected]
• Saira Jahangir
  [email protected]

Locations (1)

Find similar trials in Chicago, IL